Lipocalin 2 orchestrates resistance to ferroptosis via AXL
Cell Reports · 2026
DOI: 10.1016/j.celrep.2026.116965 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026. Verfasst von Sabrina Z Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Sciences, Cleveland Clinic Research, Cleveland, OH, USA; Medical Scientist Training Program (MSTP), School of Medicine, Case Wes…. Hauptthemen laut MEDLINE: Lipocalin-2, Receptor Protein-Tyrosine Kinases, Proto-Oncogene Proteins, Ferroptosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NINDS NIH HHS, National Institutes of Health National Cancer Institute.
Abstract (Originalsprache)
Glioblastoma (GBM) remains a lethal tumor, largely due to robust mechanisms that prevent effective induction of cell death. Ferroptosis, a form of iron-dependent cell death, is a promising vulnerability in GBM. Here, we demonstrate that lipocalin-2 (LCN2) suppresses ferroptosis in GBM cells via the receptor tyrosine kinase AXL. LCN2 was elevated in GBM cells compared to lower-grade tumor and non-transformed cells, and Lcn2 knockdown impaired GBM cell fitness and growth in vitro and in vivo. Mechanistically, Lcn2 knockdown triggered ferroptosis, which was specifically rescued with ferroptosis inhibitors but not apoptosis or necroptosis inhibitors. Lcn2 knockdown reduced AXL phosphorylation, which was elevated in GBM patient tumors relative to non-tumor tissue. Notably, the combination of Lcn2 knockdown and pharmacological AXL inhibition extended survival compared to Lcn2 knockdown alone. Taken together, these data reveal a link between LCN2-mediated suppression of ferroptosis with AXL phosphorylation and support this axis as a potential therapeutic target for GBM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cancer Sciences, Cleveland Clinic Research, Cleveland, OH, USA; Medical Scientist Training Program (MSTP), School of Medicine, Case Western Reserve University, Cleveland, OH, USA; Department of Pathology,…
- Department of Cancer Sciences, Cleveland Clinic Research, Cleveland, OH, USA.
- Department of Cancer Sciences, Cleveland Clinic Research, Cleveland, OH, USA; Medical Scientist Training Program (MSTP), School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
- Department of Cancer Sciences, Cleveland Clinic Research, Cleveland, OH, USA; Case Comprehensive Cancer Center, Cleveland, OH, USA; Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case W…
- Department of Cancer Sciences, Cleveland Clinic Research, Cleveland, OH, USA; Case Comprehensive Cancer Center, Cleveland, OH, USA; Department of Pathology, Cleveland Clinic Lerner College of Medicine of Case Western Re…
- Department of Pediatrics, McDonnell Pediatric Research Building, Washington University in St. Louis, St. Louis, MO, USA.
Förderung
- NCI NIH HHS
- NINDS NIH HHS
- National Institutes of Health National Cancer Institute
- Cleveland Clinic
- National Institute of Neurological Disorders and Stroke
- National Institutes of Health
- Case Comprehensive Cancer Center, Case Western Reserve University
- American Brain Tumor Association
Zitieren
APA
Wang, S. Z., Timken, J. P., Hong, E. S., Kaur, S., Newby, E., Kay, K. E., Mulkearns-Hubert, E. E., Silver, D. J., Lee, J., Rubin, J. B., Connor, J. R., Deleyrolle, L. P., Tiek, D., Dhawan, A., & Lathia, J. D. (2026). Lipocalin 2 orchestrates resistance to ferroptosis via AXL. Cell Reports. https://doi.org/10.1016/j.celrep.2026.116965
Vancouver
Wang SZ, Timken JP, Hong ES, Kaur S, Newby E, Kay KE, et al. Lipocalin 2 orchestrates resistance to ferroptosis via AXL. Cell Reports. 2026. doi:10.1016/j.celrep.2026.116965
BibTeX
@article{Wang2026,
author = {Wang, Sabrina Z and Timken, J Payton and Hong, Ellen S and Kaur, Sehaj and Newby, Eli and Kay, Kristen E and Mulkearns-Hubert, Erin E and Silver, Daniel J and Lee, Juyeun and Rubin, Joshua B and Connor, James R and Deleyrolle, Loic P and Tiek, Deanna and Dhawan, Andrew and Lathia, Justin D},
title = {Lipocalin 2 orchestrates resistance to ferroptosis via AXL},
journal = {Cell Reports},
year = {2026},
doi = {10.1016/j.celrep.2026.116965}
}
EUVIMED